European Archives - Page 1104 of 1227 - European Medical Journal

How to Improve Your Success in Treating Mild and Moderate Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) describes two inflammatory conditions of the gastrointestinal tract: ulcerative colitis (UC) and Crohn’s disease (CD)…

EMJ

‘Leaky’ Vessels Answer to Unresponsive Cancer

PROMISING research, which has implications for the development of treatments for medulloblastoma, the most common brain tumour in children, has emerged…

EMJ

Brain Rewiring After Stroke May be Answer to Therapy

RECOVERY following a stroke can be difficult, but a new study gives an insight into potential recovery markers and new treatment options.

Beyond the Gut: The Importance of Controlling Systemic Inflammation in Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) management goals have recently focussed on gastrointestinal symptom resolution and mucosal healing. IBD causes systemic…

EMJ Gastroenterology 5 [Suppl 7] 2016

Inflammatory bowel disease (IBD) management goals have recently focussed on gastrointestinal symptom resolution and mucosal healing.

EMJ

Celyad announces oral presentation on NKR-2 T Cells Manufacturing for a First-in-Human Clinical Trial in AML and Multiple Myeloma

Mont-Saint-Guibert, Belgium – Celyad (Euronext Brussels and Paris, and NASDAQ: CYAD), a leader in the discovery and development of engineered cell…

EMJ

Otometrics and Maastrict University Drive Greater Understanding of the Paradigm Shift in Vestibular Assessment with New Master Class

Taastrup, Denmark | April 7, 2016 – GN Otometrics, the leading global manufacturer of hearing and balance instrumentation will host a two-day vestibular…

EMJ

Circadian Clock in Kidneys Plays Role in Metabolic Processes

RHYTHMIC processes of bodily function, such as urine excretion, are regulated by an internal circadian clock located in the kidney organs, a new study…

EMJ

New Mechanisms of Bladder Function Offer Target for Therapy

SENSORY nerve activity mediating the function of the bladder is influenced by both filling pressure and newly discovered ‘non-voiding transient…

EMJ

Glycotope Appoints Dr. Alfredo Zurlo as Chief Medical Officer

Berlin, Germany, April 29, 2016 – Glycotope GmbH, a clinical-stage immuno-oncology company built on world-leading glyco-biology expertise, today…